Deutsche Bank maintained a Buy rating on Mindray Medical (NYSE: MR) and reduced its price target to $40.00 (from $43.50) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE